Circulating autoantibody to CD25 may be a potential biomarker for early diagnosis of esophageal squamous cell carcinoma

scientific article published on 20 February 2013

Circulating autoantibody to CD25 may be a potential biomarker for early diagnosis of esophageal squamous cell carcinoma is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1007/S12094-013-1007-3
P698PubMed publication ID23423807

P2093author name stringC Zhang
B Liu
S Sun
J Wei
K-H Lee
S Guan
P2860cites workSerum p53 antibody is a useful tumor marker in superficial esophageal squamous cell carcinomaQ73104080
Circulating p53 antibodies, p53 gene mutational profile and product accumulation in esophageal squamous-cell carcinoma in IndiaQ73527255
Pathology of esophageal cancers: local experience and current insightsQ74568566
Autoantibodies in breast cancer: their use as an aid to early diagnosisQ79905914
The variation of CD4+CD25+ regulatory T cells in the periphery blood and tumor microenvironment of non-small cell lung cancer patients and the downregulation effects induced by CpG ODNQ84192939
Activation of regulatory T cells instigates functional down-regulation of cytotoxic T lymphocytes in human breast cancerQ84945701
Foxp3 programs the development and function of CD4+CD25+ regulatory T cellsQ27860714
Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseasesQ28131652
The inhibitory cytokine IL-35 contributes to regulatory T-cell functionQ28258462
Regulatory T cells and immune toleranceQ29616864
Proteomics-based approach identifying autoantibody against peroxiredoxin VI as a novel serum marker in esophageal squamous cell carcinomaQ33262742
Proteomics-based identification of autoantibody against heat shock protein 70 as a diagnostic marker in esophageal squamous cell carcinomaQ33323321
Anti-CDC25B autoantibody predicts poor prognosis in patients with advanced esophageal squamous cell carcinomaQ34138855
Trends in survival for both histologic types of esophageal cancer in US surveillance, epidemiology and end results areasQ34187865
Increase of regulatory T cells in metastatic stage and CTLA-4 over expression in lymphocytes of patients with non-small cell lung cancer (NSCLC).Q34638359
Autoantibodies against MMP-7 as a novel diagnostic biomarker in esophageal squamous cell carcinomaQ34744973
Tumor-evoked regulatory B cells promote breast cancer metastasis by converting resting CD4⁺ T cells to T-regulatory cellsQ34987934
Derangement of immune responses by myeloid suppressor cellsQ35573513
EarlyCDT®-Lung test: improved clinical utility through additional autoantibody assaysQ36285345
Serum autoantibodies as biomarkers for early cancer detectionQ37622471
Are circulating autoantibodies to ABCC3 transporter a potential biomarker for lung cancer?Q51331951
A study of circulating anti-CD25 antibodies in non-small cell lung cancer.Q54250692
A dominant function for interleukin 27 in generating interleukin 10-producing anti-inflammatory T cells.Q55045567
Esophageal CancerQ56209683
Gr-1+CD115+ Immature Myeloid Suppressor Cells Mediate the Development of Tumor-Induced T Regulatory Cells and T-Cell Anergy in Tumor-Bearing HostQ57054792
P433issue10
P921main subjectbiomarkerQ864574
esophageal squamous cell carcinomaQ108442577
P304page(s)825-829
P577publication date2013-02-20
P1433published inClinical and Translational OncologyQ15754324
P1476titleCirculating autoantibody to CD25 may be a potential biomarker for early diagnosis of esophageal squamous cell carcinoma
P478volume15

Reverse relations

cites work (P2860)
Q51364917A panel of autoantibodies as potential early diagnostic serum biomarkers in patients with breast cancer.
Q55473534Alteration of circulating natural autoantibodies to CD25-derived peptide antigens and FOXP3 in non-small cell lung cancer.
Q90318254Autoantibodies: Potential clinical applications in early detection of esophageal squamous cell carcinoma and esophagogastric junction adenocarcinoma
Q86360571Circulating autoantibody to FOXP3 may be a potential biomarker for esophageal squamous cell carcinoma
Q54382756Detection of circulating antibodies to linear peptide antigens derived from ANXA1 and DDX53 in lung cancer.
Q26865552Esophageal cancer: Recent advances in screening, targeted therapy, and management
Q91829072Further Study of Circulating Antibodies to P16, CD25 and FOXP3 in Hepatocellular Carcinoma
Q36694379Further study of circulating IgG antibodies to CD25-derived peptide antigens in nonsmall cell lung cancer
Q38272640Serum autoantibodies in the early detection of esophageal cancer: a systematic review
Q45935803Study of circulating antibodies against CD25 and FOXP3 in breast cancer.
Q34037876Use of autoantibodies to detect the onset of breast cancer

Search more.